A Randomized, Double-blinded, Placebo-controlled Phase 2 study of (ERC1671/ GM-CSF / Cyclophosphamide) + Bevacizumab vs. (Placebo Injection / Placebo pill) + Bevacizumab in the treatment of recurrent/progressive, Bevacizumab naïve glioblastoma multiforme and gliosarcoma patients (WHO grade IV malignant gliomas)

UCI-13-14
NCT01903330
Cancer - Brain and Nervous System
Daniela Bota
Open
Treatment
Avastin, Bevacizumab, Cyclophosphamide, Cytoxan, ERC1671, GM-CSF, Placebo
Vaccine
II
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.